Prostate-cancer-associated I260M variant of DNA polymerase β is a sequence-specific mutator

Shibani Dalal, Suzanne Hile, Kristin A. Eckert, Ka Wai Sun, Daniela Starcevic, Joann B. Sweasy

Research output: Contribution to journalArticlepeer-review

65 Scopus citations


Studies show that 30% of 189 tumors sequenced to date express variants of the polymerase β (pol β) protein that are not present in normal tissue. This raises the possibility that variants of pol β might be linked to the etiology of cancer. Here, we characterize the I260M prostate-cancer- associated variant of pol β. Ile260 is a key residue of the hydrophobic hinge that is important for the closing of the polymerase. In this study, we demonstrate that the I260M variant is a sequence context-dependent mutator polymerase. Specifically, I260M is a mutator for misalignment-mediated errors in dipyrimidine sequences. I260M is also a low-fidelity polymerase with regard to the induction of transversions within specific sequence contexts. Our results suggest that the hinge influences the geometry of the DNA within the polymerase active site that is important for accurate DNA synthesis. Importantly, characterization of the I260M variant shows that it has a functional phenotype that could be linked to the etiology or malignant progression of human cancer.

Original languageEnglish (US)
Pages (from-to)15664-15673
Number of pages10
Issue number48
StatePublished - Dec 6 2005
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry


Dive into the research topics of 'Prostate-cancer-associated I260M variant of DNA polymerase β is a sequence-specific mutator'. Together they form a unique fingerprint.

Cite this